C. Olsen

发表

Structure-Activity Relationships of Nociceptin Receptor (NOP) Ligands and the Design of Bifunctional NOP/Mu Opioid Receptor-Targeted Ligands

P. Daga, N. Zaveri, D. Yasuda, 2013 .

Characterization of opiates, neuroleptics, and synthetic analogs at ORL1 and opioid receptors.

J. Lewis, N. Zaveri, L. Toll, 2001, European journal of pharmacology.

Activity of new NOP receptor ligands in a rat peripheral mononeuropathy model: potentiation of morphine anti-allodynic activity by NOP receptor antagonists.

J. Orduña, N. Zaveri, L. Toll, 2009, European journal of pharmacology.

Comparison of the Antinociceptive and Antirewarding Profiles of Novel Bifunctional Nociceptin Receptor/μ-Opioid Receptor Ligands: Implications for Therapeutic Applications

N. Zaveri, L. Toll, W. Polgar, 2009, Journal of Pharmacology and Experimental Therapeutics.

Activities of mixed NOP and μ‐opioid receptor ligands

G. Calo’, S. Husbands, J. Lewis, 2008, British journal of pharmacology.

The synthesis and biological activity of two analogs of the anti‐HIV alkaloid michellamine B

M. Dawson, J. Lawson, A. Pandey, 1996 .

Replacement of the peptide-backbone amides connecting Tyr-Gly and Gly-Gly in leucine-enkephalin with ketomethylene groups: synthesis and biological activity.

E. Uyeno, L. Toll, C. Olsen, 1984, Journal of medicinal chemistry.

Isolation and characterization of a new atrial peptide-degrading enzyme from bovine kidney.

L. Toll, S. Brandt, C. Olsen, 1991, Biochemical and biophysical research communications.

Small-molecule agonists and antagonists of the opioid receptor-like receptor (ORL1, NOP): Ligand-based analysis of structural factors influencing intrinsic activity at NOP

N. Zaveri, L. Toll, W. Polgar, 2005, The AAPS Journal.

A novel series of piperidin-4-yl-1,3-dihydroindol-2-ones as agonist and antagonist ligands at the nociceptin receptor.

J. Deschamps, N. Zaveri, L. Toll, 2004, Journal of medicinal chemistry.

SR 16435 [1-(1-(Bicyclo[3.3.1]nonan-9-yl)piperidin-4-yl)indolin-2-one], a Novel Mixed Nociceptin/Orphanin FQ/μ-Opioid Receptor Partial Agonist: Analgesic and Rewarding Properties in Mice

J. Orduña, N. Zaveri, L. Toll, 2007, Journal of Pharmacology and Experimental Therapeutics.

JPET #111997 Title Page SR 16435 (1-(1-bicyclo[3.3.1]nonan-9-yl)piperidin-4-yl)indolin-2-one), A Novel Mixed NOP/μ−Opioid Receptor Partial Agonist: Analgesic and Rewarding Properties in Mice

Jiang, N. Zaveri, W. Polgar, 2006 .

Novel mu-selective Met-enkephalinamide analogs with antagonist activity. Synthesis, receptor binding, analgesic properties and conformational studies.

J. Lawson, E. Uyeno, L. Toll, 2009, International journal of peptide and protein research.

Novel α3β4 nicotinic acetylcholine receptor-selective ligands. Discovery, structure-activity studies, and pharmacological evaluation.

N. Zaveri, L. Toll, W. Polgar, 2010, Journal of medicinal chemistry.

Designing bifunctional NOP receptor-mu opioid receptor ligands from NOP receptor-selective scaffolds. Part I.

N. Zaveri, L. Toll, W. Polgar, 2013, Bioorganic & medicinal chemistry letters.